Exabis Library
Welcome to the e-CCO Library!
DOP23: Single-cell RNA sequencing identifies an important role for class I histone-deacetylase enzymes in intestinal myofibroblasts from patients with Crohn’s Disease strictures
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP23: The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP24 Patient-reported health-related quality-of-life outcomes with vedolizumab vs. adalimumab treatment of ulcerative colitis: Results of the VARSITY trial
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP24: Crohn’s Disease fistula show skewed lymphoid/myeloid balance, altered myeloid cell profiles and high TNF-α expression
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP24: Early life exposures and risk for inflammatory bowel disease: a nested case-control study in Quebec, Canada
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP24: Intestinal acidification sensed by pH-sensing receptor GPR4 contributes to fibrogenesis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
DOP24: Japan prospective multicenter study for optimization of COVID-19 vaccinations based on the immune response and safety profile in Inflammatory Bowel Disease patients: Interim analyses of the J-COMBAT trial
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP24: Multi-omic sequencing reveals distinctive gene expression and DNA methylation alterations as potential predictors of primary sclerosing cholangitis development in treatment-naïve paediatric Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP25 Medication use and comorbidities among elderly when compared with younger patients with inflammatory bowel disease in the TARGET-IBD cohort
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
DOP25: Antibodies against Neutrophil Extracellular Traps (ANETAs) are associated with more severe disease course in Ulcerative Colitis
2024
ECCO'24 Stockholm
Tuesday, 30 April 2024, 5:03 PM
DOP25: Association of Enterobacteriaceae with Crohn’s Disease subtypes during remission
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
DOP25: Clinical outcomes of COVID-19 and Impact on Disease Course in Patients with Inflammatory Bowel Disease
2022
ECCO'22
Friday, 11 February 2022, 3:52 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 2:22 PM
DOP25: Contraceptive method use according to Inflammatory Bowel Disease status among young women in the United States
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 10:43 AM
DOP25: Medication use and comorbidities among elderly as compared to younger patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 5:40 PM
DOP25: Medication use and comorbidities among elderly as compared to younger patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort
2020
ECCO'20 Vienna
Tuesday, 23 June 2020, 4:58 PM
1
DOP25: Unraveling Vedolizumab mechanism of action in Ulcerative Colitis
2019
ECCO'19 Copenhagen
Tuesday, 28 May 2019, 3:32 PM
1
DOP25: Unravelling vedolizumab mechanism of action in ulcerative colitis
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM